Back to mobile site

Barclays Starts Sutro Biopharma (STRO) at Overweight

May 28, 2026 3:36 AM EDT Send to a Friend
(Updated - May 28, 2026 3:43 AM EDT)

Barclays analyst Lukas Shumway initiates coverage on Sutro Biopharma (NASDAQ: STRO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login